metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Hepatoprotective effect of nifedipine against ischemia-reperfusion injury in rat...
Información de la revista
Vol. 19. Núm. S1.
Abstracts of the 2020 Annual meeting of the Mexican Association of Hepatology (AMH) – XV Congreso Nacional de Hepatología (23-25 de julio)
Páginas 10 (septiembre 2020)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 19. Núm. S1.
Abstracts of the 2020 Annual meeting of the Mexican Association of Hepatology (AMH) – XV Congreso Nacional de Hepatología (23-25 de julio)
Páginas 10 (septiembre 2020)
20
Open Access
Hepatoprotective effect of nifedipine against ischemia-reperfusion injury in rats
Visitas
1054
A. Villarreal-Benítez, P. Cordero-Pérez, N.F. Cruz-Urista, E. Cienfuegos-Pecina, D. Villarreal-Garza, D.P. Moreno-Peña, L. Muñoz-Espinosa, L.C. Treviño-Lozano, L. Torres-González
Centro de Hepatología, Medicina Interna, Hospital Universitario “Dr. José E. González”, Nuevo León, Monterrey, México
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Descargar PDF
Estadísticas
Figuras (1)
Texto completo

Background and aim: Ischemia-reperfusion (IR) injury is the leading cause of early graft dysfunction. Many mechanisms are involved in IR injury; activation of apoptosis is one of the most important. The blockade of the Ca2+ channels inhibits apoptosis and has a potential protector effect against IR injury. Calcium channel blockers, like nifedipine, have potential therapeutic activity against this process in organs such as brain, testicle and intestine. In this project, we aimed to assess the hepatoprotective effect of nifedipine in our IR model.

Material and methods: A total of 18 female Wistar rats were divided into three groups: Sham (SH), IR, and nifedipine+IR (NIR, 10mg/kg, p.o., twice a day for three days). A midline laparotomy was performed, exposing the liver hilum and inducing IR injury to the IR and NIR groups, by using an atraumatic vascular clamp (ischemia: 20min; reperfusion: 1 hour). Serum activities of ALT, AST, LDH, and ALP, and serum concentrations of total bilirubin and glucose were measured. Proinflammatory cytokines (IL-1β, IL-6, and TNF-α) were determined, and oxidative stress biomarkers (superoxide dismutase, malondialdehyde, and glutathione peroxidase) were assessed. Histological parameters, such as congestion, vacuolization, and necrosis, were evaluated in tissue samples stained with hematoxylin and eosin. All rats were handled according to the Official Mexican Norm NOM-062-ZOO-1999. This project was approved by the Ethics and Research Committee of our Institution with registry: HI19-00003.

Results: The administration of nifedipine caused a decrease in the serum activities of ALT and AST compared against the IR group. Also, it caused an increase in the activity of ALP probably caused by osteoclastic induction due to nifedipine. The concentration of glucose and total bilirubin compared with the SH group showed an elevation (Figure). There were no significant differences in the other parameters analyzed.

Figure.

Biochemical and inflammation markers. *p<0.05 against SH. #p<0.05 against IR.

(0.16MB).

Conclusions: Nifedipine presents a hepatoprotective effect against IR injury, evidenced by the decrease of liver enzymes. This compound does not show an immunomodulator or antioxidant effect.

Conflicts of interest: The authors have no conflicts of interest to declare.

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2020.08.057
No mostrar más